Disc Medicine, Inc. (IRON)
(Delayed Data from NSDQ)
$47.75 USD
+0.28 (0.59%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $47.76 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth B Momentum D VGM
Disc Medicine, Inc. (IRON) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$66.10 | $85.00 | $40.00 | 39.25% |
Price Target
Based on short-term price targets offered by 10 analysts, the average price target for Disc Medicine, Inc. comes to $66.10. The forecasts range from a low of $40.00 to a high of $85.00. The average price target represents an increase of 39.25% from the last closing price of $47.47.
Analyst Price Targets (10)
Broker Rating
Disc Medicine, Inc. currently has an average brokerage recommendation (ABR) of 1.30 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 1.30 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 80% and 10% of all recommendations. A month ago, Strong Buy made up 80%, while Buy represented 10%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 7 | 7 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.30 | 1.30 | 1.30 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/20/2024 | Cantor Fitzgerald & Co | Kristen Kluska | Strong Buy | Strong Buy |
9/16/2024 | H.C. Wainwright & Co. | Douglas Tsao | Strong Buy | Strong Buy |
8/22/2024 | Wells Fargo Securities | Tiago Fauth | Not Available | Strong Buy |
8/9/2024 | Wedbush Securities | David M Nierengarten | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/8/2024 | Raymond James | Danielle Brill | Moderate Buy | Moderate Buy |
5/29/2024 | SVB Securities | Thomas J Smith | Strong Buy | Strong Buy |
4/2/2024 | BMO Capital Markets | Evan Seigerman | Strong Buy | Strong Buy |
3/1/2024 | LifeSci Capital | Rami Katkhuda | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.30 |
ABR (Last week) | 1.30 |
# of Recs in ABR | 10 |
Average Target Price | $66.10 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 86 of 252 |
Current Quarter EPS Est: | -0.98 |
IRON FAQs
Disc Medicine, Inc. (IRON) currently has an average brokerage recommendation (ABR) of 1.30 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms.
The average price target for Disc Medicine, Inc. (IRON) is $66.10. The current on short-term price targets is based on 8 reports.
The forecasts for Disc Medicine, Inc. (IRON) range from a low of $40 to a high of $85. The average price target represents a increase of $38.43 from the last closing price of $47.75.
The current UPSIDE for Disc Medicine, Inc. (IRON) is 38.43%
Based on short-term price targets offered by 10 analysts, the average price target for Disc Medicine, Inc. comes to $66.10. The forecasts range from a low of $40.00 to a high of $85.00. The average price target represents an increase of 39.25% from the last closing price of $47.47.